Lv0
0 积分 2024-12-09 加入
TLD: An optimized liposomal doxorubicin formulation with small vesicle size for improved anti-tumor efficacy
1个月前
已完结
Intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for neoadjuvant treatment of high-risk early breast cancer (GeparOcto-GBG 84): A randomised phase III trial
3个月前
已完结
Addition of Carboplatin to Sequential Taxane-Anthracycline Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Phase III Randomized Controlled Trial
6个月前
已完结
Carboplatin for Premenopausal Triple-Negative Breast Cancer: Time to Rethink the Neoadjuvant Standard?
6个月前
已完结
Study assesses normal tissue effects after axillary radiotherapy for early breast cancer
6个月前
已完结
Efficacy comparisons of solvent-based paclitaxel, liposomal paclitaxel, nanoparticle albumin-bound paclitaxel, and docetaxel after neoadjuvant systemic treatment in breast cancer
7个月前
已完结
皖公网安备34019202002308
